Phase 1/2 dose escalation trial of the prostate-specific membrane antigen (PSMA)targeted immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer (CRPC) Meeting Abstract

  

Authors:	Milowsky, M. I.; Galsky, M.; Lewin, J.; Rozario, C. P.; Owens, L.; Marshall, T.; Nanus, D.; Webb, I. J.; Scher, H. I.
Abstract Title:	Phase 1/2 dose escalation trial of the prostate-specific membrane antigen (PSMA)targeted immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer (CRPC)
Meeting Title:	41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	23
Issue:	16 Suppl.
Meeting Dates:	2005 May 13-17
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2005-06-01
Start Page:	406S
Language:	English
ACCESSION:	WOS:000230326602443
PROVIDER:	wos
DOI:	10.1200/jco.2005.23.16_suppl.4615
Notes:	--- - Meeting Abstract: 4615 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/44768